CodaMetrix

AI Coding Automation for Revenue Cycle

Boston, Massachusetts, United States

Multi-specialty autonomous medical coding platform.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out CodaMetrix on @MedStartr Today Multi-specialty autonomous medical coding platform. #Gastroenterology #ClaimsRevenueCycleAI #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/iSljqRIWRoY

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in CodaMetrix

How We Help

Problem Statement

Manual medical coding is a significant challenge for healthcare organizations, leading to high operational costs, coding inaccuracies, claim denials, and delays in revenue collection.

Core Technology

autonomous medical coding platform

Key Differentiators

Rated #1 Best in KLAS for autonomous medical coding (2026); Platform automates medical coding across a wide range of specialties.

Clinical Focus

Radiology; Pathology; Gastroenterology; Surgery; Evaluation and Management; General Acute Care

Company Info

Business Model: SaaS
Founded: 2021
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.codametrix.com/

Disease Areas

Gastroenterology

Technologies

Machine LearningNLPAutonomous Medical CodingRevenue Cycle ManagementGenerative AIAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Real-world evidence from Mass General Brigham academic health system partnership; deployed across 500+ hospitals supporting 60M+ patient visits; 70% manual coding reduction, 60% denial reduction, 5-week cash acceleration proven in production.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of CodaMetrix?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.